BACKGROUND: The best method to deliver intraperitoneal chemotherapy (IPC) for peritoneal carcinomatosis from ovarian cancer is not well defined. The aim of this study was to assess the ability of hyperthermia and adrenaline to enhance the intratumoral accumulation of cisplatin in a rat model of peritoneal carcinomatosis. METHODS: Four groups of 5 BDIX rats with ovarian peritoneal carcinomatosis underwent IPC with 30 mg/l of cisplatin according to the following conditions: normothermia at 37° for 1 or 2 hours, hyperthermia at 42°C for 1 hour or normothermia at 37°C for 2 hours with 2 mg/l adrenaline. Tissue platinum content was measured by atomic absorption spectroscopy. The effect of hyperthermia, adrenaline and the duration of exposure to the drug was measured in vivo (tissue concentration of platinum in tumor, abdominal and extra abdominal tissues) and in vitro (cytotoxicity on human ovarian cancer cells). RESULTS: In vitro, hyperthermia and longer exposure enhanced the accumulation and the cytotoxic effect of cisplatin on cancer cells. In vivo, only the 2 hours treatment with adrenaline resulted in increased platinum concentrations. The rats treated with adrenaline showed significantly lower concentrations of cisplatin in extra peritoneal tissues than those treated with hyperthermia. CONCLUSION: Adrenaline is more effective than hyperthermia in order to enhance the intratumoral concentration of cisplatin in rats with peritoneal carcinomatosis from ovarian origin. It may also decrease the systemic absorption of the drug.
BACKGROUND: The best method to deliver intraperitoneal chemotherapy (IPC) for peritoneal carcinomatosis from ovarian cancer is not well defined. The aim of this study was to assess the ability of hyperthermia and adrenaline to enhance the intratumoral accumulation of cisplatin in a rat model of peritoneal carcinomatosis. METHODS: Four groups of 5 BDIX rats with ovarian peritoneal carcinomatosis underwent IPC with 30 mg/l of cisplatin according to the following conditions: normothermia at 37° for 1 or 2 hours, hyperthermia at 42°C for 1 hour or normothermia at 37°C for 2 hours with 2 mg/l adrenaline. Tissue platinum content was measured by atomic absorption spectroscopy. The effect of hyperthermia, adrenaline and the duration of exposure to the drug was measured in vivo (tissue concentration of platinum in tumor, abdominal and extra abdominal tissues) and in vitro (cytotoxicity on humanovarian cancer cells). RESULTS: In vitro, hyperthermia and longer exposure enhanced the accumulation and the cytotoxic effect of cisplatin on cancer cells. In vivo, only the 2 hours treatment with adrenaline resulted in increased platinum concentrations. The rats treated with adrenaline showed significantly lower concentrations of cisplatin in extra peritoneal tissues than those treated with hyperthermia. CONCLUSION:Adrenaline is more effective than hyperthermia in order to enhance the intratumoral concentration of cisplatin in rats with peritoneal carcinomatosis from ovarian origin. It may also decrease the systemic absorption of the drug.
Authors: Cécile Molucon-Chabrot; Nicolas Isambert; Laurent Benoit; Sylvie Zanetta; Jean Fraisse; Jean-Claude Guilland; Bernard Royer; Pascale Monin-Baroille; Michel Flesch; Pierre Fargeot; Bruno Coudert; Françoise Mayer; Pierre Fumoleau; Bruno Chauffert Journal: Anticancer Drugs Date: 2006-11 Impact factor: 2.248
Authors: F Raspagliesi; S Kusamura; J C Campos Torres; G A de Souza; A Ditto; F Zanaboni; R Younan; D Baratti; L Mariani; B Laterza; M Deraco Journal: Eur J Surg Oncol Date: 2006-04-18 Impact factor: 4.424
Authors: C Duvillard; L Benoit; P Moretto; J L Beltramo; P Brunet-Lecomte; M Correia; C Sergent; B Chauffert Journal: Int J Cancer Date: 1999-05-31 Impact factor: 7.396
Authors: Bruno Chauffert; Patrick Favoulet; Emmanuel Polycarpe; Christian Duvillard; Jean-Luc Beltramo; Francis Bichat; Patrick Rat; Philippe Genne; Laurent Benoit Journal: Surg Oncol Clin N Am Date: 2003-07 Impact factor: 3.495
Authors: G Los; P Sminia; J Wondergem; P H Mutsaers; J Havemen; D ten Bokkel Huinink; O Smals; D Gonzalez-Gonzalez; J G McVie Journal: Eur J Cancer Date: 1991 Impact factor: 9.162
Authors: Michelle M Boisen; Scott D Richard; Matthew P Holtzman; Robert P Edwards; Joseph L Kelley; Mohammad Haroon Choudry; David Bartlett; Marilyn Huang Journal: J Gastrointest Oncol Date: 2016-02
Authors: B Royer; E Kalbacher; S Onteniente; V Jullien; D Montange; S Piedoux; A Thiery-Vuillemin; D Delroeux; S Pili-Floury; E Guardiola; M Combe; P Muret; V Nerich; B Heyd; B Chauffert; J-P Kantelip; X Pivot Journal: Br J Cancer Date: 2011-12-15 Impact factor: 7.640
Authors: Min Jeong Jeon; Cheol-Hee Ahn; Hyeonjin Kim; In Jae Chung; Seulhee Jung; Young-Hwa Kim; Hyewon Youn; Jin Wook Chung; Young Il Kim Journal: J Exp Clin Cancer Res Date: 2014-07-18